Keywords: migraine, prophylaxis, drug, market, forecasts, emerging, agents

Migraine prophylaxis drug market forecasts

Article | 15 November 2004

Print This

Emerging agents' more manageable side effects will increase diagnosis rates and the use of pharmacologic prophylaxis for migraine in the ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in